RT Journal Article
SR Electronic
T1 Effectiveness of a COVID-19 contact tracing app in a simulation model with indirect and informal contact tracing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.15.23291010
DO 10.1101/2023.06.15.23291010
A1 Leung, Ka Yin
A1 Metting, Esther
A1 Ebbers, Wolfgang
A1 Veldhuijzen, Irene
A1 Andeweg, Stijn P.
A1 Luijben, Guus
A1 de Bruin, Marijn
A1 Wallinga, Jacco
A1 Klinkenberg, Don
YR 2023
UL http://medrxiv.org/content/early/2023/06/20/2023.06.15.23291010.abstract
AB During the COVID-19 pandemic, contact tracing was used to identify individuals who had been in contact with a confirmed case so that these contacted individuals could be tested and quarantined to prevent further spread of the SARS-CoV-2 virus. Many countries developed mobile apps to find these contacted individuals faster. We evaluate the epidemiological effectiveness of the Dutch app CoronaMelder, where we measure effectiveness as the reduction of the reproduction number R. To this end, we use a simulation model of SARS-CoV-2 spread and contact tracing, informed by data collected during the study period (December 2020 - March 2021) in the Netherlands. We show that the tracing app caused a clear but small reduction of the reproduction number, and the magnitude of the effect was found to be robust in sensitivity analyses. The app could have been more effective if more people had used it, and if time intervals between symptom onset and reporting of contacts would have been shorter. The model used is novel as it accounts for the clustered nature of social networks and as it accounts for cases informally alerting their contacts directly after symptom onset, without involvement of health authorities or a tracing app.Competing Interest StatementThe authors have declared no competing interest.Funding Statement This study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Centre for Clinical Expertise at the National Insitute for Public Health and the Environment (RIVM) is of the opinion that the research does not fulfill the conditions of the law (WMO) and therefore conclude approval by ethical research committee or institutional review board is deemed unnecessary by current national legislation.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll parameter values, code and simulation data used for analysis and visualization are available on Github (https://github.com/rivm-syso/cm-evaluation) https://github.com/rivm-syso/cm-evaluation